Stephen Pincock
This person does not yet have a bio.Articles by Stephen Pincock

Presenting Her Majesty ...
Stephen Pincock | | 3 min read
The Queen on the screen. Susannah Eliott (CEO of the Australian Science Media Centre) at the lectern, and the three scientists sitting nearby (l-r: John Long, Kate Trinajstic and Tim Senden). Credit: courtesy of Sarah Long" />The Queen on the screen. Susannah Eliott (CEO of the Australian Science Media Centre) at the lectern, and the three scientists sitting nearby (l-r: John Long, Kate Trinajstic and Tim Senden)

A Planck Walk
Stephen Pincock | | 6 min read
A Planck Walk © Edgar Zippel, Berlin / www.edgarzippel.de A shift in focus - and a couple of robots - have helped researchers at a Max Planck Institute pinpoint the genetics underlying entire systems. By Stephen Pincock Related Articles 1-3 For some time, systems biology as a concept garnered less than the full support of the biological community, Lehrach notes. "There are a few people who really understand and push it, but some who are opposed," he

Swiss Structures
Stephen Pincock | | 3 min read
Swiss Structures Justin Hession Photography /1 in September 2006, it led to a complete rethinking of ABC transporter structure - and the retraction of five earlier papers on related structures.2 (A software error had led Geoffrey Chang, the young US researcher who had published those earlier articles, to inadvertently mistake the handedness of the molecule.) Locher, a steely character with short dark hair and rimless glasses, suggests that Chang's blunder

An abattoir saves the day
Stephen Pincock | | 2 min read
An abattoir saves the day By Stephen Pincock Article Extras Swiss Structures When Timm Maier arrived at Nenad Ban's lab at ETH Zurich in early 2004, he was looking for a project that would push him to his limits. Not long before, ETH's Simon Jenni had obtained well-diffracting crystals of fungal fatty acid synthase, so Maier decided to go after its mammalian analogue. Justin Hession Photography /www.justinhession.ch Nenad Ban (left) and T

Watching Wolfson
Stephen Pincock | | 10 min read
Watching Wolfson In 12 years, the UK institute has produced 600 papers, 6 spin-offs, and 31 patents. Does this mean its unique approach is working? By Stephen Pincock Related Articles 1 and new details on how a nitric oxide-cGMP-dependent pathway controls mitochondrial biogenesis and the body's energy balance.2,3 The standout feature of the institute is the way it has managed to achieve genuine interaction among researchers of different disciplines,

Spun Out
Stephen Pincock | | 1 min read
Spun out: Companies born at Wolfson The Wolfson Institute for Biomedical Research was established to bring together the best of industry and academia, so it isn't surprising that several spinout companies have emerged from its walls in recent years. By Stephen Pincock Related Articles Watching Wolfson Ark Therapeutics (1997) has several products in late-stage clinical development, including a gene-based therapy for glioma with orphan drug sta

Building Vaccine Consensus
Stephen Pincock | | 7 min read
By Stephen PincockBIOBUSINESSWhen Klaus Stöhr left the World Health Organization to take a job at the Swiss drug giant Novartis in February, there were some who questioned whether the most prominent figure in the global fight against avian influenza had forsaken public health for profit margins. "I don't see why this should be good news," wrote one blogger with the moniker "gsgs" on a site devoted to pandemic flu soon after t

Sense prevails on MRI rules
Stephen Pincock | | 1 min read
Scientists in Europe have been expressing linkurl:relief;http://www.guardian.co.uk/science/2007/oct/22/medicalresearch.health this week at the news that the European Union is dropping rules on the levels of radiation medical staff can be exposed to. The EU physical agents directive had triggered linkurl:consternation;http://www.the-scientist.com/article/display/22775/ a couple of years ago, with researchersworried it would be impossible to do certain kinds of studies and keep within the prescri

Stem cell work under investigation
Stephen Pincock | | 3 min read
Australian researcher working under new CIRM president Alan Trounson submitted false progress reports

Q&A: Leszek Borysiewicz
Stephen Pincock | | 5 min read
The new head of the UK's Medical Research Council discusses the challenges ahead

Koalas vs. chlamydia
Stephen Pincock | | 3 min read
Prepping a koala for a procedure Credit: Courtesy of Stephen Pincock" />Prepping a koala for a procedure Credit: Courtesy of Stephen Pincock Peering through a fringe of eucalyptus leaves, Don the koala greets visitors with an air of unmistakable curiosity. His large and sensitive nose can easily detect the scent of unfamiliar humans, but his tiny eyes seem much less useful. Swollen and half covered by inflamed eyelids, they've been reduced to slits by debilitating conjunctivitis.

Slideshow: Saving koalas from chlamydia
Stephen Pincock | | 1 min read
Slideshow: Saving koalas from chlamydia Scientists are on the hunt for a vaccine to save one of Australia's most celebrated species var FO = { movie:"http://www.the-scientist.com/supplementary/flash/53654/koala.swf", width:"520", height:"580", majorversion:"8", build:"0"}; UFO.create(FO, "ufoDemo"); Please download the Adobe Flash Player to view this content:

MRC confirms new chief
Stephen Pincock | | 3 min read
Imperial College vaccinologist to head UK biomedical research

UK approves hybrid embryos
Stephen Pincock | | 2 min read
Public voices support for the controversial research technique
Page 1 of 20 - 295 Total Items